Tackling visual impairment: emerging avenues in ophthalmology
Visual impairment, stemming from genetic, degenerative, and traumatic causes, affects millions globally. Recent advancements in ophthalmology present novel strategies for managing and potentially reversing these conditions. Here, we explore 10 emerging avenues—including gene therapy, stem cell thera...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1567159/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849310549319352320 |
|---|---|
| author | Fang Lin Yuxing Su Chenxi Zhao Farhana Akter Shun Yao Sheng Huang Xiaodong Shao Yizheng Yao |
| author_facet | Fang Lin Yuxing Su Chenxi Zhao Farhana Akter Shun Yao Sheng Huang Xiaodong Shao Yizheng Yao |
| author_sort | Fang Lin |
| collection | DOAJ |
| description | Visual impairment, stemming from genetic, degenerative, and traumatic causes, affects millions globally. Recent advancements in ophthalmology present novel strategies for managing and potentially reversing these conditions. Here, we explore 10 emerging avenues—including gene therapy, stem cell therapy, advanced imaging, novel therapeutics, nanotechnology, artificial intelligence (AI) and machine learning, teleophthalmology, optogenetics, bionics, and neuro-ophthalmology—all making strides to improve diagnosis, treatment, and vision restoration. Among these, gene therapy and stem cell therapy are revolutionizing the treatment of retinal degenerative diseases, while advanced imaging technologies enable early detection and personalized care. Therapeutic advancements like anti-vascular endothelial growth factor therapies and neuroprotective agents, along with nanotechnology, have improved clinical outcomes for multiple ocular conditions. AI, especially machine learning, is enhancing diagnostic accuracy, facilitating early detection, and personalized treatment strategies, particularly when integrated with advanced imaging technologies. Teleophthalmology, further strengthened by AI, is expanding access to care, particularly in underserved regions, whereas emerging technologies like optogenetics, bionics, and neuro-ophthalmology offer new hope for patients with severe vision impairment. In light of ongoing research, we summarize the current clinical landscape and the potential advantages of these innovations to revolutionize the management of visual impairments. Additionally, we address the challenges and limitations associated with these emerging avenues in ophthalmology, providing insights into their future trajectories in clinical practice. Continued advancements in these fields promise to reshape the landscape of ophthalmic care, ultimately improving the quality of life for individuals with visual impairments. |
| format | Article |
| id | doaj-art-005fd96ea8f14e788ab936e91a3f468b |
| institution | Kabale University |
| issn | 2296-858X |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj-art-005fd96ea8f14e788ab936e91a3f468b2025-08-20T03:53:42ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-04-011210.3389/fmed.2025.15671591567159Tackling visual impairment: emerging avenues in ophthalmologyFang Lin0Yuxing Su1Chenxi Zhao2Farhana Akter3Shun Yao4Sheng Huang5Xiaodong Shao6Yizheng Yao7Department of Ophthalmology, Xinjiang 474 Hospital, China RongTong Medical Healthcare Group CO. LTD, Urumqi, Xinjiang Uygur Autonomous Region, ChinaDepartment of Ophthalmology, Xinjiang 474 Hospital, China RongTong Medical Healthcare Group CO. LTD, Urumqi, Xinjiang Uygur Autonomous Region, ChinaDepartment of Ophthalmology, Xinjiang 474 Hospital, China RongTong Medical Healthcare Group CO. LTD, Urumqi, Xinjiang Uygur Autonomous Region, ChinaFaculty of Arts and Sciences, Harvard University, Cambridge, MA, United StatesDepartment of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Ophthalmology, TongRen Municipal People’s Hospital, Tongren, Guizhou, ChinaDepartment of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, ChinaDepartment of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu, ChinaVisual impairment, stemming from genetic, degenerative, and traumatic causes, affects millions globally. Recent advancements in ophthalmology present novel strategies for managing and potentially reversing these conditions. Here, we explore 10 emerging avenues—including gene therapy, stem cell therapy, advanced imaging, novel therapeutics, nanotechnology, artificial intelligence (AI) and machine learning, teleophthalmology, optogenetics, bionics, and neuro-ophthalmology—all making strides to improve diagnosis, treatment, and vision restoration. Among these, gene therapy and stem cell therapy are revolutionizing the treatment of retinal degenerative diseases, while advanced imaging technologies enable early detection and personalized care. Therapeutic advancements like anti-vascular endothelial growth factor therapies and neuroprotective agents, along with nanotechnology, have improved clinical outcomes for multiple ocular conditions. AI, especially machine learning, is enhancing diagnostic accuracy, facilitating early detection, and personalized treatment strategies, particularly when integrated with advanced imaging technologies. Teleophthalmology, further strengthened by AI, is expanding access to care, particularly in underserved regions, whereas emerging technologies like optogenetics, bionics, and neuro-ophthalmology offer new hope for patients with severe vision impairment. In light of ongoing research, we summarize the current clinical landscape and the potential advantages of these innovations to revolutionize the management of visual impairments. Additionally, we address the challenges and limitations associated with these emerging avenues in ophthalmology, providing insights into their future trajectories in clinical practice. Continued advancements in these fields promise to reshape the landscape of ophthalmic care, ultimately improving the quality of life for individuals with visual impairments.https://www.frontiersin.org/articles/10.3389/fmed.2025.1567159/fullgene therapystem cell therapynanotechnologyartificial intelligenceteleophthalmologyoptogenetics |
| spellingShingle | Fang Lin Yuxing Su Chenxi Zhao Farhana Akter Shun Yao Sheng Huang Xiaodong Shao Yizheng Yao Tackling visual impairment: emerging avenues in ophthalmology Frontiers in Medicine gene therapy stem cell therapy nanotechnology artificial intelligence teleophthalmology optogenetics |
| title | Tackling visual impairment: emerging avenues in ophthalmology |
| title_full | Tackling visual impairment: emerging avenues in ophthalmology |
| title_fullStr | Tackling visual impairment: emerging avenues in ophthalmology |
| title_full_unstemmed | Tackling visual impairment: emerging avenues in ophthalmology |
| title_short | Tackling visual impairment: emerging avenues in ophthalmology |
| title_sort | tackling visual impairment emerging avenues in ophthalmology |
| topic | gene therapy stem cell therapy nanotechnology artificial intelligence teleophthalmology optogenetics |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2025.1567159/full |
| work_keys_str_mv | AT fanglin tacklingvisualimpairmentemergingavenuesinophthalmology AT yuxingsu tacklingvisualimpairmentemergingavenuesinophthalmology AT chenxizhao tacklingvisualimpairmentemergingavenuesinophthalmology AT farhanaakter tacklingvisualimpairmentemergingavenuesinophthalmology AT shunyao tacklingvisualimpairmentemergingavenuesinophthalmology AT shenghuang tacklingvisualimpairmentemergingavenuesinophthalmology AT xiaodongshao tacklingvisualimpairmentemergingavenuesinophthalmology AT yizhengyao tacklingvisualimpairmentemergingavenuesinophthalmology |